Latest Breaking News On - வேலா ரீட் - Page 1 : comparemela.com

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Artios Pharma Announces Collaboration with Novartis to Create Next Generation DDR Cancer Therapies Artios Pharma, Inc.April 7, 2021 GMT Novartis to leverage Artios’ discovery platform to identify DDR targets for use with Novartis’ proprietary radioligand therapies. Artios to receive US$20 million up-front payment in addition to near term research funding to support the collaboration. Artios eligible to receive up to $1.3 billion in discovery, development, regulatory and sales-based milestones in addition to royalty payments. CAMBRIDGE, United Kingdom and NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting synthetic lethality to develop a broad pipeline of precision medicines for the treatment of cancer, today announced a global research collaboration with Novartis to discover and validate next generatio

New yorkUnited statesUnited kingdomCity ofArtios pharmaArix bioscienceAbid ansariNiall martinVela reidSv health investorsArtios pharma limitedMerck kgaIp groupInstitute of cancer researchCancer research united kingdomMerck kgaa